Zetia

Type: Product
Name: Zetia
First reported Sep 02 2014 - Updated Sep 03 2014 - 1 reports

A new game-changing therapy in preventing heart disease? Regeneron and Sanofi think so.

In what may be the most important development in the management of coronary heart disease (CHD) since the discovery of statins, clinical trials of an antibody called alirocumab—which is being developed by Regeneron and Sanofi—have produced some astounding ... [Published American Council On Science & Health - Sep 02 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

3 Reasons Merck & Co., Inc.'s Stock Could Fall

If you were lucky enough to time your purchase of Merck ( NYSE: MRK     ) during the heights of the Great Recession, your investment has probably seen a return of 100% or greater. Unfortunately, timing the stock market is practically impossible to do, ... [Published Motley Fool Discussion Boards - Aug 28 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

A cause for celebration

Happy birthday to Al Roker, who makes even a rainy day forecast seem jolly. Happy birthday to Amy Adams, who enchanted audiences in movies as diverse as Drop Dead Gorgeous, The Fighter, and American Hustle. Happy birthday to the late Jacqueline Susann, ... [Published Lexology - Aug 22 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Buy rating on Glenmark Pharma

Summary Glenmark announced discovery of its first bi-specific antibody, GBR 1302.Glenmark announced discovery of its first bi-specific antibody, GBR 1302. This bispecific molecule has been developed using Glenmark’s proprietary antibody engineering platform ... [Published Financial Express - Aug 22 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

A Cause for Celebration

Happy birthday to Al Roker, who makes even a rainy day forecast seem jolly.  Happy birthday to Amy Adams, who enchanted audiences in movies as diverse as Drop Dead Gorgeous , The Fighter , and American Hustle .  Happy birthday to the late Jacqueline ... [Published Drug and Device Law - Aug 20 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

AHA announces late-breaking clinical trials for annual Scientific Sessions

The American Heart Association has announced the line-up of late-breaking clinical trials slated for presentation at its annual Scientific Sessions in Chicago.According to a press release, the meeting will feature four late-breaking clinical trial sessions ... [Published Orthopedics Today - Aug 13 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

SUNY Oneonta chemistry professor's discovery earns patent

A local chemistry professor is the second SUNY Oneonta faculty member to receive a U.S. patent, according to a recent media release from the college.Dr. Jacqueline Bennett, an associate professor of chemistry and biochemistry at the State University College ... [Published New York Daily Star - Aug 13 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

Merck & Co posts net profit of $2,004 million in Q2

Merck & Co has registered strong growth in profits during the second quarter ended June 2014 despite lower sales. Its net profit increased by 121 per cent to $2,004 million from $906 million in the corresponding period of last year. However, its net sales ... [Published PharmaBiz - Aug 05 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Merck 2Q profit more than doubles

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations. The maker of popular Type 2 diabetes pill Januvia and ... [Published The Washington Times stories: News - Jul 29 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Why are doctors still prescribing Zetia?

A health research company just released a list of the 100 top drugs in America according to sales. 29th on the list, with sales of over $1.8 billion, is the cholesterol lowering drug ezetimibe, brand name Zetia. Continue reading ... Your patients ... [Published KevinMD.com - Jul 10 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

There They Go Again - Merck Threatened Legal Action Against Italian Doctor who Criticized Zetia

It seems that when confronted with unfavorable facts or opinions, Merck executives like to threaten legal action, rather than just argue their side of the case.  Last month we discussed how Merck officials used the US court system to try to prevent ... [Published Health Care Renewal - Jul 08 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Larry Husten writes

Merck Uses Legal Threats To Stifle Negative Advice About Zetia And Vytorin In Italy In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug. The drug, ezetimibe, is a key ingredient ... [Published PharmaGossip - Jul 07 2014]

Quotes

...While other companies have had success buying clinical-stage hepatitis C drugs -- just look at Gilead Sciences " $11 billion purchase of Pharmasset, which yielded the now-blockbuster drug Sovaldi -- Idenix's pipeline has been riddled with disappointments throughout the years."
"When I was first experimenting with the method, I missed what was happening because I was writing in my notebook," Bennett said. "To my surprise, the compound, which looks like gold glitter, formed after only a few minutes. Other methods require hours of boiling. This worked so well and so quickly. I tried it again and again to see if it was true. I thought, ‘This is fabulous.’"
"Although we cannot comment on the likelihood of approval based solely on specific indications or populations" two drugs recently were approved based on cholesterol-lowering for people with inherited conditions, she noted

More Content

All (23) | News (16) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Sanofi: Riding The Growth Trend [Published Seeking Alpha - Sep 09 2014]
A new game-changing therapy in preventing heart... [Published American Council On Science & Health - Sep 02 2014]
Regeneron/Sanofi Presents Encouraging Alirocuma... [Published Zacks.com - Sep 02 2014]
Regeneron/Sanofi Presents Encouraging Alirocuma... [Published Zacks.com - Sep 02 2014]
Alirocumab bests ezetimibe for LDL reduction in... [Published Orthopedics Today - Aug 31 2014]
3 Reasons Merck & Co., Inc.'s Stock Could Fall [Published Motley Fool Discussion Boards - Aug 28 2014]
A cause for celebration [Published Lexology - Aug 22 2014]
Buy rating on Glenmark Pharma [Published Financial Express - Aug 22 2014]
A Cause for Celebration [Published Drug and Device Law - Aug 20 2014]
AHA announces late-breaking clinical trials for... [Published Orthopedics Today - Aug 13 2014]
SUNY Oneonta chemistry professor's discovery ea... [Published New York Daily Star - Aug 13 2014]
Should You Be Taking a Statin? [Published US News & World Report - Aug 12 2014]
Merck & Co posts net profit of $2,004 million i... [Published PharmaBiz - Aug 05 2014]
Merck 2Q profit more than doubles [Published The Washington Times stories: News - Jul 29 2014]
Why are doctors still prescribing Zetia? [Published KevinMD.com - Jul 10 2014]
There They Go Again - Merck Threatened Legal Ac... [Published Health Care Renewal - Jul 08 2014]
Larry Husten writes [Published PharmaGossip - Jul 07 2014]
Global Genomics Group ("G3") Appoints Harry "Ch... [Published PR Newswire: Health - May 06 2014]
Merck & Co net earnings moves up by 7% in Q1 [Published PharmaBiz - Apr 30 2014]
New drugs greatly lower cholesterol, studies show [Published Lehigh Valley Live - Mar 30 2014]
Studies Find New Drugs Greatly Lower Cholesterol [Published TIME.com - Mar 29 2014]
Patent expiration, stagnant R&D spend seriously... [Published PharmaBiz - Mar 28 2014]
Fact Sheet for Schering Plough Corporation [Published Able2Act - Jan 09 2008]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
A Cause for Celebration [Published Drug and Device Law - Aug 20 2014]
Happy birthday to Al Roker, who makes even a rainy day forecast seem jolly.  Happy birthday to Amy Adams, who enchanted audiences in movies as diverse as Drop Dead Gorgeous , The Fighter , and American Hustle .  Happy birthday to the late Jacqueline ...
Why are doctors still prescribing Zetia? [Published KevinMD.com - Jul 10 2014]
A health research company just released a list of the 100 top drugs in America according to sales. 29th on the list, with sales of over $1.8 billion, is the cholesterol lowering drug ezetimibe, brand name Zetia. Continue reading ... Your patients ...
There They Go Again - Merck Threatened Legal Ac... [Published Health Care Renewal - Jul 08 2014]
It seems that when confronted with unfavorable facts or opinions, Merck executives like to threaten legal action, rather than just argue their side of the case.  Last month we discussed how Merck officials used the US court system to try to prevent ...
Larry Husten writes [Published PharmaGossip - Jul 07 2014]
Merck Uses Legal Threats To Stifle Negative Advice About Zetia And Vytorin In Italy In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug. The drug, ezetimibe, is a key ingredient ...
Global Genomics Group ("G3") Appoints Harry "Ch... [Published PR Newswire: Health - May 06 2014]
RICHMOND, Va., May 6, 2014 /PRNewswire/ -- Global Genomics Group (G3), a life sciences company investigating biological networks that lead to the development of disease to identify novel diagnostic biomarkers and therapeutic targets, today announced the ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.